A glycine-serine-alanine-rich peptide ameliorates Alzheimer-type neurodegeneration.
Si-Yuan YaoJia-Fan WangZheng XuYue MengYue XueFan YangWen-Bing YaoXiang-Dong GaoSong ChenPublished in: British journal of pharmacology (2023)
Our study provides foundations for development of glycine-serine-alanine repeat peptides especially SNP-9 as potential therapeutic interventions for AD.